|
|
News Breaks
|
November 18, 2009
|
| 07:42 EDT |  | CLDA |
| theflyonthewall.com: | Clinical Data initiates Phase III Stedivaze trial | | Clinical Data announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze for use as a pharmacologic stress agent in myocardial perfusion imaging, a method for detecting defects in the blood supply to the heart. The Phase III trial will also compare the tolerability of Stedivaze to adenosine, a standard pharmacologic stress agent used in MPI scans. :theflyonthewall.com |
|
|
News For CLDA From The Last 14 Days Check below for free stories on CLDA the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
